To infect per os, baculovirus virions cross the peritrophic matrix (PM) to reach the midgut epithelium. Insect intestinal mucins (IIMs) are PM proteins that protect the PM and aid passage of the food bolus through the gut. Some baculoviruses, including Mamestra configurata nucleopolyhedrovirus (MacoNPV-A), encode metalloproteases, known as enhancins, that facilitate infection by degrading IIMs. We examined the interaction between MacoNPV-A enhancin and M. configurata IIMs both in vivo and in vitro. Per os inoculation of M. configurata larvae with MacoNPV-A occlusion bodies (OBs) resulted in the degradation of McIIM4 within 4 h of OB ingestion, while McIIM2 was unaffected. The PM recovered by 8 h post-inoculation. To investigate whether enhancin was responsible for the degradation of IIM, a recombinant Autographa californica multiple nucleopolyhedrovirus expressing MacoNPV enhancin (AcMNPVenMP2) was constructed. Enhancin was found to be a component of occlusion-derived virions in AcMNPV-enMP2 and MacoNPV-A. In in vitro assays, McIIM4 was degraded after MacoNPV-A and AcMNPV-enMP2 treatments. Degradation of McIIM4 was inhibited by EDTA, a metalloprotease inhibitor, indicating that the degradation was due to enhancin activity. Thus, MacoNPV-A enhancin is able to degrade major structural PM proteins, but exhibits target substrate specificity.
INTRODUCTION
The family Baculoviridae includes arthropod-specific viruses with large, circular, covalently closed, dsDNA genomes of between 80 and 180 kbp. The family includes four genera: Alphabaculovirus [formerly known as Nucleopolyhedrovirus (NPV)], members of which infect lepidopteran hosts; Betabaculovirus [Granulovirus (GV)]; Gammabaculovirus (hymenopteran-specific NPV); and Deltabaculovirus (dipteran-specific NPV) (Jehle et al., 2006) . Baculoviruses have two virion phenotypes, budded virus (BV) and occlusionderived virus (ODV). BVs are formed early in the infection cycle when nucleocapsids bud through the host-cell membrane and acquire an envelope. The BVs are responsible for cell-to-cell transmission of the virus within the host insect. Late in the infection cycle, nucleocapsids are enveloped (single or multiple nucleocapsids per virion) by membranes formed within the infected host-cell nucleus and these virions are subsequently occluded within proteinaceous crystals or occlusion bodies (OBs). These ODVs are infectious to insect midgut cells upon ingestion by a susceptible host.
In order for baculovirus ODVs to infect insect midgut cells, they must first cross the peritrophic matrix (PM), a semipermeable sheath that is composed of chitin microfibrils and proteins, lining the midgut of most insect species (Wang & Granados, 1997a) . The PM protects the midgut epithelium from mechanical damage, toxic compounds and pathogens, regulates nutrient uptake by compartmentalizing digestive processes and prevents excretion of digestive enzymes by providing a means for enzyme recycling (reviewed by Hegedus et al., 2009) . The protective feature of the PM is in part due to insect intestinal mucins (IIMs) that are common and predominant features of the insect PMs (Toprak et al., 2010a) . These proteins contain O-glycosylated regions referred to as mucin domains (MDs) that are important in protecting the PM from physical or chemical damage and protease degradation (Wang & Granados, 1997a; Devenport et al., 2006) .
Early studies showed that co-feeding of GV OBs with NPV OBs significantly increased the infectivity and virulence of the NPV for its natural host even in the absence of any actual GV infection (Tanada, 1959; Yamamoto & Tanada, 1978; Zhu et al., 1989) . In the case of Trichoplusia ni granulovirus (TnGV), this enhancement of NPV infectivity was linked to degradation of the host insect PM and increased PM permeability caused by a metalloprotease, enhancin, that was associated with the OBs (Lepore et al., 1996; Peng et al., 1999) . Virus-enhancing activity of purified enhancin has been well-documented in betabaculoviruses (Gallo et al., 1991; Wang et al., 1994; Wang & Granados, 1998) . Further evidence for this was provided by experiments that used a recombinant Autographa californica multiple nucleopolyhedrovirus (AcMNPV) expressing TnGV enhancin (Lepore et al., 1996) . Similar approaches have been used for alphabaculoviruses; for example, the LD 50 value of a recombinant AcMNPV expressing MacoNPV enhancin was 4.4 times lower than that of wild-type AcMNPV in secondinstar Trichoplusia ni larvae (Li et al., 2003) . As well, deletion of enhancin genes in Lymantria dispar multiple nucleopolyhedrovirus (LdMNPV) decreased virus potency, confirming that it enhances activity of this virus (Bischoff & Slavicek, 1997; Popham et al., 2001) .
TnGV enhancin was the first baculovirus enhancin gene to be sequenced (Hashimoto et al., 1991) . One to four enhancin genes are found in the genomes of numerous betabaculoviruses (reviewed by Galloway et al., 2005) , as well as in a few group II alphabaculoviruses (reviewed by Galloway et al., 2005; Thiem, 2009) , including Mamestra configurata nucleopolyhedrovirus (MacoNPV-A and MacoNPV-B) (Li et al., 2002a, b) . MacoNPV-A enhancin (GenBank accession no. AAM09197; Li et al., 2003 Li et al., , 2005 is an 847 aa protein with a zinc-binding domain typical of metalloproteases. It contains a potential transmembrane domain (aa 804-826) followed by a series of basic amino acid residues at its carboxy terminus. Although both alpha-and betabaculovirus enhancins are produced during the late phase of infection (Bischoff & Slavicek, 1997) , there are basic structural differences. For example, TnGV enhancin was demonstrated to constitute approximately 5 % of the protein composition of OBs and was released upon solubilization of OBs in alkaline OB dissolution buffer (Gallo et al., 1991; Roelvink et al., 1995) . In contrast, Western blots of fractionated ODVs and immunoelectron microscopy localization studies of LdMNPV enhancin showed that it is present in ODV envelopes, perhaps in association with nucleocapsids as well (Slavicek & Popham, 2005) . Furthermore, analysis of alpha-and betabaculovirus enhancin amino acid sequences predicts the presence of a putative transmembrane domain at the carboxy terminus in alphabaculovirus enhancins, but not in betabaculovirus enhancins, in accordance with the findings on localization of GV versus NPV enhancins Slavicek & Popham, 2005) .
A limited number of studies have attempted to address the mode of action of enhancins. Early studies pointed to an interaction between betabaculovirus enhancins and the PM (Derksen & Granados, 1988) . Enhancin purified from TnGV OBs degraded T. ni TnIIM in vivo and in vitro (Wang & Granados 1997a, b) . As a consequence of this interaction, the permeability of Pseudaletia unipuncta and T. ni PMs to AcMNPV virions and blue dextran was increased (Peng et al., 1999) . However, studies on the mode of action of alphabaculovirus enhancin are quite limited. Experiments with MacoNPV-A showed that unprocessed or partially processed forms of McIIM1 were degraded after per os challenge of Mamestra configurata larvae, suggesting that IIMs may be common targets for both enhancin types (Shi et al., 2004) . Recently, Hoover et al. (2010) demonstrated that double enhancin deletion constructs of LdMNPV were six times less infectious than wild type in oral bioassays, while inhibition of PM formation by an optical brightener resulted in a 14-fold decrease in infectivity for the double enhancin deletion in LdMNPV compared with the wild type. These authors concluded that alphabaculovirus enhancin interacts with other potential targets in the midgut epithelium in addition to the PM, thus suggesting an additional mechanism for enhancin activity.
In the current study, localization of MacoNPV-A enhancin and its impact, as a representative of alphabaculovirus enhancins, on different IIM types are investigated.
RESULTS

Characterization of MacoNPV-A enhancin
Phylogenetic analysis of baculovirus enhancins and enhancin-like metalloproteases from Bacillus spp. and Yersinia spp. indicated that MacoNPV enhancins are related more closely to enhancins from group II NPVs and bacterial enhancin-like metalloproteases than to enhancins from GVs (Fig. 1) . The only group I NPV in which an enhancinlike gene has been identified, Choristoneura fumiferana multiple nucleopolyhedrovirus (CfMNPV), was an outlier in the NPV group, and the LdMNPV enhancin cluster, which included Euproctis pseudoconspersa nucleopolyhedrovirus (EupsNPV), was even more distantly related (Fig. 1) .
Western blot analysis using anti-MacoNPV-A enhancin antiserum detected an approximately 108 kDa band in ODV and OB preparations from MacoNPV-A (Fig. 2) . In contrast, no MacoNPV-A enhancin was detected in Western blots of MacoNPV-A solubilized OB protein samples, which were composed largely of polyhedrin protein (data not shown). The presence of nucleocapsids in the ODV and OB preparations was confirmed by Western blot analyses using anti-MacoNPV VP39 antibody, while nucleocapsids were not detected in the purified solubilized OB protein sample (data not shown). The antiMacoNPV-A enhancin antiserum also reacted with a band of approximately 108 kDa in the AcMNPV-enMP2 ODV and OB preparations, but did not react with any protein band in the AcMNPV-wt lanes (Fig. 2) . This confirms that MacoNPV-A enhancin is expressed as a late gene in the AcMNPV-enMP2 recombinant (Li et al., 2003) , and it was translated and incorporated into ODVs as it is in the native MacoNPV-A virus (Fig. 2) .
Oral-exposure assays SDS-PAGE profiles of strongly associated PM protein fractions from control and MacoNPV-A-challenged larvae (5.0610 5 OBs per larva) were similar at 2, 6, 12 and 24 h post-inoculation (p.i.). In contrast, the protein profile at 4 h p.i. from the PMs from MacoNPV-A-challenged larvae (Fig. 3b ) differed from that of uninfected control larvae (Fig. 3a) , as additional bands between 34 and 95 kDa were present. It should be noted that a protein of 32 kDa, demonstrated earlier to be predominantly soybean lectin, GmLe1, originating from the diet (Toprak et al., 2008) , binds to PM carbohydrate and increased gradually with time in PM protein samples from both control and MacoNPV-A-challenged larvae (r in Fig. 3a, b) . Fig. 1 . Phylogenetic analysis of known baculovirus and bacterial enhancins. Enhancin amino acid sequences were aligned using CLUSTAL_X and a neighbour-joining tree was generated. The final unrooted tree was generated using PHYLIP software. Numbers on each branch indicate the frequency of a given tree branch after bootstrap analysis (out of 100 replicates). Proteins included in the analysis were betabaculovirus enhancins from AgseGV, ChfuGV, HearGV, PsunGV, TnGV, XecnGV 1-4; alphabaculovirus enhancins from AgipNPV, Agse The anti-McIIM2 antiserum reacted strongly with a protein of approximately 130 kDa and weakly with two higher-molecular-mass proteins (¢170 kDa) in the PMs of both control ( Fig. 3c ) and MacoNPV-A-challenged ( Fig.  3d ) larvae at all time points. The anti-McIIM4 antiserum reacted strongly with a protein of approximately 170 kDa, which is probably the fully processed form of McIIM4, in PM protein samples from control ( Fig. 3e) and MacoNPV-A-challenged ( Fig. 3f ) larvae at all time points. The major difference was that the anti-McIIM4 antiserum reacted with multiple proteins between 25 and 86 kDa in the PM sample from MacoNPV-A-challenged larvae at 4 h p.i. (Fig. 3f ). In the control samples, the antiserum also reacted with proteins of 70 (denoted by # in Fig. 3e ) and 88 kDa ($ in Fig. 3e ) that may represent the unglycosylated and partially glycosylated forms of McIIM4. These proteins were not observed in the samples from MacoNPV-Achallenged larvae. Finally, a protein of approximately 46 kDa (, in Fig. 3f ) was present in the samples from MacoNPV-A-challenged larvae at 12 and 24 h p.i. Several other proteins common to both MacoNPV-A-challenged and control larvae cross-reacted with the McIIM4 antiserum. These included the 32 kDa protein band containing soybean lectin, which was found to increase gradually with time (r in Fig. 3e , f).
To test whether MacoNPV enhancin expressed in the recombinant virus AcMNPV-enMP2 interacted similarly with T. ni PM, an oral-exposure assay was undertaken. Western blot analysis of the PM proteins associated with faecal pellets from fifth-instar larvae, using an anti-TnIIM antibody, was done as described previously (Wang & Granados, 1997a) . The PM associated with faecal pellet samples showed predominantly high-molecular-mass bands at .200 kDa, approximately 200 kDa and between 116 and 97 kDa (Fig. 4) . For larvae challenged with AcMNPVenMP2 OBs or Fluorescent Brightener 28 (FB28), the .200 kDa band (*), which represents the fully glycosylated form of TnIIM, was less abundant than for samples from larvae challenged with AcMNPV-E2 OBs, mock-infected or buffer control. These results suggest that the fully glycosylated form of TnIIM was degraded to a limited extent in the presence of FB28 and AcMNPV-enMP2 OBs.
In vitro-exposure assays
Western blot analysis with the anti-McIIM4 antiserum revealed numerous additional proteins, ranging from 22 to 52 kDa, in the M. configurata PM sample incubated with solubilized MacoNPV-A OBs (Fig. 5) . These bands were absent in the control, indicating that they were McIIM4 degradation products.
To examine whether the degradation of McIIM4 was due to enhancin activity, a second set of in vitro experiments was conducted using two additional viruses: AcMNPV-wt, which lacks an enhancin gene, and the recombinant virus AcMNPV-enMP2, which expresses the MacoNPV-A enhancin. Incubation of M. configurata PM with solubilized MacoNPV-A OBs revealed proteins ranging from 22 to 39 kDa (denoted by * in Fig. 6 ) and several of these proteins were also observed in PMs treated with AcMNPVenMP2 OBs, although the 34 and 39 kDa degradation products were not detected. None of the degradation products were observed in the AcMNPV-wt or control samples. In addition, in the presence of the metalloprotease inhibitor EDTA, these proteins were not detected in the MacoNPV-A and AcMNPV-enMP2 OB treatments, indicating that McIIM4 degradation was due to MacoNPV-A enhancin. No degradation products derived from McIIM2 were detected in any of these virus treatments (data not shown), in accordance with the result of the per os feeding experiment above.
DISCUSSION
Most of the basic characterization of baculovirus enhancins derives from studies of betabaculovirus enhancins and, in particular, TnGV enhancin. These studies revealed that betabaculovirus enhancins are associated with OBs . Studies on alphabaculovirus enhancins are limited and relate mostly to LdMNPV (Bischoff & Slavicek, 1997) and MacoNPV-A (Li et al., 2003) . These studies revealed that alphabaculovirus enhancins have a transmembrane domain (Bischoff & Slavicek, 1997) and are present in ODV envelopes in association with nucleocapsids (Slavicek & Popham, 2005) . The current study also revealed that MacoNPV-A enhancin is associated with ODVs. As this is the second NPV enhancin demonstrated to be associated with ODV, it suggests that localization of alphabaculovirus enhancin to the ODV membrane could be a common feature. However, analysis of additional NPV enhancins is required to confirm this hypothesis.
Phylogenetic studies of enhancin-like metalloproteases from baculoviruses have demostrated that alpha-and betabaculovirus enhancins form two distinct clades, suggesting different phylogenetic origins (Jakubowska et al., 2006 ). In the current study, we have expanded the range of baculovirus enhancins included in the phylogenetic analysis and have reached a similar conclusion regarding differing phylogenetic origins of NPV and GV enhancins, which separate into two distinct clusters. The NPV enhancin cluster includes enhancin-like metalloproteases from Grampositive bacteria. Interestingly, the only group I NPV enhancin (CfMNPV) appeared to be an outlier in the main NPV enhancin clade and the LdMNPV enhancins appeared to be even more distantly related (Fig. 1) . These results support the results of enhancin localization, which suggest a major dichotomy between NPV and GV enhancins.
Western blot analysis using anti-McIIM4 antiserum revealed multiple bands between 25 and 86 kDa, representing the degradation products of McIIM4, in the PM protein samples from M. configurata larvae at 4 h p.i. with MacoNPV-A. Shi et al. (2004) also reported that McIIM1 was degraded 4 h after MacoNPV-A challenge, suggesting that both McIIM1 and McIIM4 are degraded shortly after ingestion of MacoNPV-A OBs and that this may allow virions to pass through the PM to the midgut epithelium. Interestingly, the fully glycosylated form, represented by a band of approximately 170 kDa, was present at all time points p.i., suggesting that the glycosylation level is a major factor affecting McIIM4 susceptibility to degradation by enhancin. Shi et al. (2004) reported the degradation of unprocessed or partially processed forms of McIIM1 after MacoNPV-A oral inoculation, while fully glycosylated forms remained intact. In contrast, McIIM2 was not affected after per os MacoNPV-A challenge. IIM glycosylation is largely O-glycosylation occurring at serine or threonine residues in the MDs. MDs comprise 32.7, 49.4 and 42.4 % of the total number of amino acid residues in McIIM1, McIIM2 and McIIM4, respectively (Shi et al., 2004; Toprak et al., 2010a) . In addition, the percentage of glycosylated serine or threonine residues within the MDs is 23.7-40.0, 70.1 and 23.5-39.7 % for McIIM1, McIIM2 and McIIM4, respectively. Thus, the largest cumulative MD contribution occurs in McIIM2 and the degree of Oglycosylation is the greatest for the McIIM2 MD. These factors may contribute to the resistance of McIIM2 to degradation by MacoNPV-A enhancin. Indeed, high Oglycosylation potential is a common feature of all binary IIMs, which were described as PM proteins with a large central MD flanked by chitin-binding domains (CBDs) (Toprak et al., 2010b) . Presumably, glycosylation protects the protein physically from proteolytic enzymes such as enhancin (Wang & Granados, 1997a) . The smaller size of MDs relative to the size of the IIM in which they are found and lower degrees of glycosylation may account for the degradation of McIIM4 and McIIM1, both of which are complex IIMs containing multiple MDs and CBDs (Toprak et al., 2010b) . Interestingly, TnIIM, which was also degraded after ingestion of baculoviral enhancin or treatment of the PM (Wang & Granados, 1997a, b) , is also a complex IIM, suggesting that IIMs of this class are sensitive to proteolysis.
The in vitro experiments were designed and carried out to maximize the number of MacoNPV ODVs interacting directly with the PM and to test whether the degradation of McIIM4 is due to MacoNPV-A enhancin. In these experiments, multiple bands between 22 and 39 kDa, representing the degradation products of McIIM4, were detected in samples extracted from PMs incubated with alkali-solubilized MacoNPV-A OBs (Fig. 5) . Treatment of PM with the AcMNPV-enMP2 resulted in a similar pattern of McIIM4 degradation to that observed for MacoNPV-A (Fig. 6) . Furthermore, no degradation was detected when the enhancin-encoding viruses were incubated with PMs in the presence of EDTA, suggesting that the degradation of McIIM4 is due to the activity of MacoNPV-A enhancin. This finding is the first demonstration of degradation of a PM protein/IIM due to an alphabaculovirus enhancin, although this has been reported for betabaculovirus enhancins. In vivo and in vitro T. ni PM assays showed that TnGV enhancin caused three high-molecular-mass glycoproteins to disappear and a ladder of new bands between 55 and 70 kDa to appear (Derksen & Granados, 1988) . In vitro assays with TnGV enhancin showed that the PM proteins of Helicoverpa zea, P. unipuncta and Spodoptera exigua were also degraded by enhancin (Wang et al., 1994) . Wang & Granados (1997a) demonstrated the specific degradation of TnIIM by TnGV enhancin in vitro and in vivo. Also, EDTA was shown to inhibit degradation of TnIIM, confirming that enhancin is a metalloprotease (Lepore et al., 1996) . Similarly, a Bacillus thuringiensis enhancin-like enzyme was shown to degrade Helicoverpa armigera IIM and to severely disrupt the PM (Fang et al., 2009 ).
Analysis of isolated PMs in in vitro experiments also confirmed the in vivo findings that the binary McIIM2 is not targeted, providing the first report of an IIM that is not degraded by baculoviral enhancins. The high glycosylation potential of this class of IIMs suggests that binary IIMs may have a conserved and critical function; this may include protection against pathogen invasion or proteolytic enzymes. This aspect could be examined further in an in vitro system using recombinant IIMs, proteases and O-glycosidases.
Interestingly, in vitro treatment of the PM with AcMNPV-wt and the no-virus control showed protein products between 42 and 54 kDa that were in common with the MacoNPV-A treatment, but were not detected in the samples from treatments containing EDTA. This may be a function of PMassociated metalloproteases (Toprak et al., 2010a) and some degradation may occur during the dissection. The dissected PM is likely to lose its integrity to a certain degree and may be less resistant to the proteolytic factors in the bolus, which is a protease-rich environment. As these experiments aimed to elucidate the role of enhancin in McIIM4 degradation, the PM was not treated with a protease inhibitor cocktail during dissection. It is also noteworthy that proteases were found to be associated with baculovirus OBs (Maskel & DiCapua, 1988) and this may also cause the degradation of McIIM4 observed with AcMNPV-wt OB in vitro.
The fact that alphabaculovirus enhancin is localized to ODVs (Slavicek & Popham, 2005 ; current study) and betabaculovirus enhancin to OB protein fractions suggests that their impact on the PM may differ. Alphabaculovirus enhancin activity is probably localized to the site of interaction of ODVs with the PM, in contrast to the more widespread degradation caused by the release of betabaculovirus enhancin after solubilization of the OBs in the midgut. Therefore, degradation of the target IIMs by alphabaculovirus enhancin may be more subtle, in contrast to the prominent degradation caused by betabaculovirus enhancins.
Initial studies on baculovirus synergistic or virulenceenhancing factors proposed that the midgut-cell membrane may be the site of action for enhancin (Tanada et al., 1980) and these cells may contain specific binding sites for enhancin (Uchima et al., 1988) . However, lower-molecular-mass TnGV OB proteins had proteolytic and virusenhancing activities, indicating that there may be multiple virus-enhancing factors associated with the OBs (Gijzen et al., 1995) . Therefore, it is necessary to examine carefully the source of virus-enhancing factor. Recently, Hoover et al. (2010) reported that an LdMNPV double enhancin deletion construct (Popham et al., 2001) was less virulent than the parent LdMNPV wild type, even when PM formation was inhibited by the inclusion of fluorescent brighteners in the diet of L. dispar. Based on these data, the authors suggested that enhancin may have an additional role, such as binding to midgut cells. Although this may indeed be the case, it is noteworthy that optical brighteners reduce sloughing (Washburn et al., 1998) and apoptosis (Dougherty et al., 2006) of midgut epithelial cells, thus adding to the complexity of infection dynamics in these bioassays.
In conclusion, the current study clearly revealed that McIIM4 is degraded by MacoNPV-A enhancin whereas McIIM2 is not, suggesting that alphabaculovirus enhancins degrade particular IIMs. This finding, in combination with studies on betabaculovirus enhancins, suggests that the virus-enhancing activity of enhancin is related to the degradation of IIMs. This is in accordance with the notion that IIMs contribute to the formation of a protective PM barrier. However, it is evident from genomic studies that many baculoviruses do not have an enhancin gene and therefore other means must exist for baculovirus virions to transit the PM. Nevertheless, understanding the roles of IIMs, in particular with respect to limiting pathogen infection of the midgut epithelium, and the features of IIMs that contribute to these roles may aid the development of new insect-control strategies. Baculovirus enhancins are promising in this regard, due to their ability to degrade the PM and promote infection by baculoviruses.
METHODS
Insects. A laboratory culture of M. configurata was maintained on a semi-synthetic diet (Bucher & Bracken, 1976 ) and larvae were reared at 21 uC, 60 % relative humidity and a 20 : 4 light/dark photoperiod. Similarly, a colony of T. ni was maintained on a high-wheatgerm artificial diet (Bell et al., 1981) and the larvae were reared at 27 uC, 60 % relative humidity and a 20 : 4 light/dark photoperiod.
Virus isolates, OB and ODV purification. Three baculoviruses were used in this study: MacoNPV-A strain 90/2 (Li et al., 2002a) , AcMNPV strain E2 and an AcMNPV recombinant, AcMNPV-enMP2, expressing MacoNPV-A enhancin under the control of its native promoter (Li et al., 2003) .
OBs were harvested from larval cadavers and further purified by centrifugation on sucrose gradients as described previously (Erlandson, 1990) . The OB stocks were adjusted to 5.0610 8 OBs ml 21 and ODV and polyhedrin fractions were isolated as follows: 100 ml OB stock was combined with 200 ml OB dissolution buffer (0.1 M Na 2 CO 3 , 0.17 M NaCl, pH 10.8) and incubated at 37 uC for 30 min to dissolve OBs and release ODV. The dissolved OB suspension was neutralized by addition of 0.05 vol. 1.0 M Tris/HCl, pH 7.5. The samples were loaded onto 50 ml 20 % sucrose cushion in Beckman 120.1 ultracentrifuge tubes and the ODVs were pelleted at 70 000 g for 30 min using a Beckman Optima benchtop ultracentrifuge. The supernatant (OB protein sample) was removed to a 1.5 ml centrifuge tube and the ODV pellet was resuspended in 50 ml TE buffer (0.01 M Tris/HCl, 0.001 M EDTA, pH 7.5).
The OB protein samples were precipitated by adding 1 M sodium acetate (pH 5) buffer to a final concentration of 0.66 M and incubating at 4 uC overnight. The precipitate was pelleted at 10 000 g in a benchtop microfuge, dried and resuspended in 50 ml TE buffer, pH 7.5. Protein concentrations of the ODV suspension and OB protein samples were determined using a standard Bradford protocol.
Phylogenetic analysis. Amino acid sequences for enhancins from the betabaculoviruses Agrotis segetum granulovirus (AgseGV), Choristoneura fumiferana granulovirus (ChfuGV), Helicoverpa armigera granulovirus (HearGV), Pseudaletia unipuncta granulovirus (PsunGV), TnGV, Xestia c-nigrum granulovirus (XecnGV); alphabaculoviruses Agrotis ipsilon nucleopolyhedrovirus (AgipNPV), Agrotis segetum nucleopolyhedrovirus (AgseNPV), CfMNPV, EupsNPV, LdMNPV, MacoNPV-A and MacoNPV-B; and bacterial enhancins from Bacillus thuringiensis, B. anthracis, B. cereus, Yersinia pestis and Y. pseudotuberculosis were subjected to phylogenetic analysis. Dendrograms arising from phylogenetic analysis were constructed according to the neighbour-joining method and confidence values for the branches were determined using bootstrap analysis where 100 trees were generated from randomly resampled data generated by CLUSTAL W 1.6, as provided in PHYLIP v. 3.5C (distributed by J. Felsenstein at http:// evolution.genetics.washington.edu/phylip). The CLUSTAL W alignment was performed using the Blosum scoring matrix with the following gap penalties: opening gap (10), end gap (10), extending gap (0.05) and separation gap (0.05).
Oral-exposure assays. One hundred fourth-instar M. configurata larvae were fed 5.0610 5 MacoNPV-A OBs per larva applied to 4 mm diameter Brassica napus leaf discs as described previously (Erlandson et al., 2007) . In parallel, 120 fourth-instar larvae fed B. napus leaf discs without virus were used as controls. PMs from 20 virus-inoculated and 20 control larvae were dissected at 2, 4, 6, 12 and 24 h p.i. and immediately washed in a droplet of ice-cold protease inhibitor cocktail (Roche Diagnostics) to remove food contents. The PM tissues were then transferred into a 1.5 ml microcentrifuge tube containing 200 ml ice-cold Ringer's solution (153 mM NaCl, 2.68 mM KCl, 1.36 mM CaCl 2 . 2H 2 O) with protease inhibitor cocktail. The integrity of McIIM2 and McIIM4 was examined by Western blots using specific polyclonal antisera as described below.
Comparative oral-exposure assays were conducted in T. ni fifth-instar larvae individually fed 1.0610
5 OBs of AcMNPV-E2 or AcMNPVenMP2, 0.025 mg FB28 (Fluorescent Brightener # 28; Sigma-Aldrich) or a buffer control using a leaf disc method. Larvae that consumed the entire disc within 60 min were transferred individually to an artificial diet and the first three faecal pellets tinged green by plant material were collected (typically within 6 h p.i.). The faecal pellets produced by each larva were homogenized in 50 ml SDS-PAGE sample buffer, processed and proteins were separated by electrophoresis on SDS-PAGE gels (10 % acrylamide). Western blot analysis was undertaken using anti-TnIIM antibody following the protocol of Wang & Granados (1997a) .
In vitro-exposure assays. Two sets of in vitro experiments were performed. In the first set, the integrity of McIIM4 was examined in PMs incubated in the presence or absence of alkali-solubilized MacoNPV-A OBs in order to confirm the in vivo data (degradation of McIIM4 upon per os inoculation). Twelve M. configurata PMs from middle-stage fourth-instar feeding larvae were dissected and rinsed in double-distilled H 2 O to remove the food bolus. The PMs were transferred to a 1.5 ml microcentrifuge tube along with 7.5610 6 MacoNPV-A OBs adjusted to a final volume of 100 ml with Ringer's solution. The suspension was mixed thoroughly using a vortex, Na 2 CO 3 and ZnCl 2 were added to final concentrations of 20 and 10 mM, respectively, and the mixture was incubated at 28 uC in a shaker (225 r.p.m.) for 1 h. An additional aliquot of 7.5610 6 MacoNPV-A OBs in 20 mM Na 2 CO 3 and 10 mM ZnCl 2 was added, mixed with a vortex and incubated overnight at 28 uC in a shaker. The following day, the mixture was centrifuged at 14 000 g and the PM pellet was washed three times in 200 ml Ringer's solution. In parallel, PMs without virus were treated and incubated in the presence of ZnCl 2 and Na 2 CO 3 using the same conditions as for the virus treatments.
The second set of experiments was designed to test whether the degradation of McIIM4 was due specifically to MacoNPV enhancin. To do this, 1.5610 7 OBs of AcMNPV-wt, AcMNPV-enMP2 or MacoNPV-A were tested using the protocol described above. In addition, the two enhancin-encoding viruses (MacoNPV-A and AcMNPV-enMP2) were tested in the presence of 10 mM EDTA, a metalloprotease inhibitor. The integrity of McIIM2 and McIIM4 was examined by Western blots using specific polyclonal antisera as described below.
Extraction of PM proteins. PMs were ground using a pestle and washed three times with 200 ml Ringer's solution with protease inhibitor cocktail. After each wash, the material was recovered by centrifugation at 20 800 g at 4 uC for 1 min and the supernatant, representing the loosely associated proteins, was discarded. The strongly associated proteins, including IIMs, were extracted from the remaining PM by grinding vigorously in a protein extraction solution of 2.5 % SDS, 5 % b-mercaptoethanol and 500 mM NaCl. This was followed by incubation at 100 uC for 5 min, at which time the supernatant was collected after centrifugation at 20 800 g for 5 min. Protein concentration was determined by the Bradford method and equal amounts of proteins were separated on SDS-PAGE gels (10 % polyacrylamide).
Protein separation and Western blot analysis. Localization of enhancin was examined in OBs, ODV and polyhedrin fractions of MacoNPV-A, AcMNPV-wt and AcMNPV-enMP2 by Western blot analysis following protein purification and separation by one-dimensional SDS-PAGE (Laemmli, 1970 ). An anti-MacoNPV-A enhancin polyclonal antiserum was developed using two synthetic peptides, STNHQCTILVYNNNRLTEET and MIANDKDLDELND-YYSSII, based on the derived amino acid sequence of MacoNPV-A ORF 89 (EZBiolab). An anti-MacoNPV-A VP39 polyclonal antibody was developed using the synthetic peptide KTAEVLAKTNPERFC, based on residues 151-165 of the derived amino acid sequence of MacoNPV-A ORF 99 (EZBiolab). The anti-AcMNPV VP39 mAb was kindly provided by Dr G. F. Rohrmann, University of Oregon, Corvallis, OR, USA.
The integrity of McIIM2 and McIIM4 was examined using specific polyclonal antisera. The anti-McIIM2 antiserum was generated against a purified recombinant protein, whereas anti-McIIM4 antiserum was generated using conjugated peptides (EzBioLab) (Toprak et al., 2010a) .
In all Western blot analyses, the proteins were electrotransferred to NitroBond nitrocellulose membrane (GE Life Sciences) in Towbin transfer buffer (Towbin et al., 1979) containing 20 % methanol. The membranes were blocked using 5 % skimmed milk powder in PBS-T buffer (137 mM NaCl, 2.7 mM KCl, 10.1 mM Na 2 HPO 4 , 1.8 mM KH 2 PO 4 , 0.2 % Tween 20, pH 7.5) overnight at 4 uC. After blocking, the membranes were incubated with the primary antiserum (1/250 to 1/1000 dilution) and then with HRP-labelled anti-rabbit IgG for 1 h each at room temperature. Secondary antibody binding was visualized using the chemiluminescence detection method with Immobilon Western detection reagents (Millipore).
